News Conference News PCR London Valves 2021 Good Results but Small Numbers With JenaValve Trilogy in Severe AR Michael O'Riordan November 26, 2021
News Conference News AHA 2021 AVATAR Supports Early SAVR in Asymptomatic Severe AS Patients L.A. McKeown November 13, 2021
News Conference News TCT 2021 TAVI Edges Out Surgery in 2-Year Costs for Low-risk Patients: PARTNER 3 Yael L. Maxwell November 05, 2021
News Conference News TCT 2021 SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years Todd Neale November 05, 2021
News Conference News EACTS 2021 TAVI Registries Offer Outcome Clues as Low-Risk Numbers Climb Shelley Wood October 20, 2021
News Conference News TCT 2021 Fracture Improves Gradients in ViV TAVI, but Ideal Timing Still Unknown Michael O'Riordan October 07, 2021
News Conference News ESC 2021 PET Imaging Detects Degeneration After TAVI as Well as Surgical, Native Valves Yael L. Maxwell September 02, 2021
News Conference News ESC 2021 2021 ESC/EACTS Valve Guidelines Unveil TAVI/SAVR Age Cutoffs and Earlier Care Shelley Wood August 31, 2021
News Conference News ESC 2021 New ESC HF Guidelines Showcase SGLT2 Inhibitors, Tafamidis, Vericiguat, and COAPT Shelley Wood August 28, 2021
News Conference News TVT 2021 Post-TAVI Pacemaker Rates Down in the US, but ‘Still Quite High’ Todd Neale July 23, 2021
News Conference News TVT 2021 TAVI Outcomes Similar in Low-Risk Bicuspid, Tricuspid Aortic Stenosis at 1 Year Todd Neale July 20, 2021
News Conference News EuroPCR 2021 Complete 2-Year Data From Evolut Low-Risk Trial ‘Reassuring’ for TAVI Yael L. Maxwell May 19, 2021
News Conference News ACC 2021 Wide Variation in TAVI Readmission Rates Among US Hospitals L.A. McKeown May 07, 2021
News Conference News CRT 2021 LRT Trial Data Bolster Support for TAVI in Bicuspid Valves L.A. McKeown March 11, 2021